<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34050501</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-1904</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</Title><ISOAbbreviation>J Neuroimmune Pharmacol</ISOAbbreviation></Journal><ArticleTitle>The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.</ArticleTitle><Pagination><StartPage>513</StartPage><EndPage>516</EndPage><MedlinePgn>513-516</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11481-021-09997-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roe</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4843-9835</Identifier><AffiliationInfo><Affiliation>, San Jose, CA, USA. kevin.roe@att.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neuroimmune Pharmacol</MedlineTA><NlmUniqueID>101256586</NlmUniqueID><ISSNLinking>1557-1890</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014122" MajorTopicYN="N">Toxoplasma</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014123" MajorTopicYN="N">Toxoplasmosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain Infections</Keyword><Keyword MajorTopicYN="N">Latent Infections</Keyword><Keyword MajorTopicYN="N">Protozoa</Keyword><Keyword MajorTopicYN="N">Protozoan Infections</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 Mortality</Keyword></KeywordList><CoiStatement>The author has no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34050501</ArticleId><ArticleId IdType="pmc">PMC8163588</ArticleId><ArticleId IdType="doi">10.1007/s11481-021-09997-0</ArticleId><ArticleId IdType="pii">10.1007/s11481-021-09997-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, Flament T, et al. Follow-up of adults with non-critical COVID-19 two months after symptoms&#x2019; onset. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M, Sansom S, Frankenberger C, Ward E, Hota B. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago,&#xa0;Illinois . Acad Emerg Med. 2020;27(10):963&#x2013;973. doi: 10.1111/acem.14104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14104</ArticleId><ArticleId IdType="pmc">PMC7436503</ArticleId><ArticleId IdType="pubmed">32762106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamer M, Gale CR, Kivim&#xe4;ki M, Batty GD. Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci USA. 2020;117(35):21011&#x2013;21013. doi: 10.1073/pnas.2011086117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2011086117</ArticleId><ArticleId IdType="pmc">PMC7474583</ArticleId><ArticleId IdType="pubmed">32788355</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med. 2020;17(9):e1003321. doi: 10.1371/journal.pmed.1003321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003321</ArticleId><ArticleId IdType="pmc">PMC7482833</ArticleId><ArticleId IdType="pubmed">32911500</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaku A, Patel V, Zacharia T, Goldenberg D, McGinn J. Guidelines for radiographic imaging of cranial neuropathies. Ear Nose Throat J. 2017;96(10&#x2013;11):E23&#x2013;E39. doi: 10.1177/0145561317096010-1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0145561317096010-1106</ArticleId><ArticleId IdType="pubmed">29121382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozloff N, Mulsant BH, Stergiopoulos V, Voineskos AN. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull. 2020;46(4):752&#x2013;757. doi: 10.1093/schbul/sbaa051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbaa051</ArticleId><ArticleId IdType="pmc">PMC7197583</ArticleId><ArticleId IdType="pubmed">32343342</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, Venter FWD. Long-COVID: an evolving problem with an extensive impact. S Afr Med J. 2020;111(1):10&#x2013;12. doi: 10.7196/SAMJ.2020.v111i11.15433.</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v111i11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemani K, Li C, Olfson M, et al. Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiat. 2021 doi: 10.1001/jamapsychiatry.2020.4442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.4442</ArticleId><ArticleId IdType="pmc">PMC7841576</ArticleId><ArticleId IdType="pubmed">33502436</ArticleId></ArticleIdList></Reference><Reference><Citation>Varikuti S, Jha BK, Vopedo G, Ryan NM, Halsey G, Hamza OM, McGwire BS, Satoskar AR. Host-directed drug therapies for neglected tropical diseases caused by protozoan parasites. Front Microbiol. 2018;9:2655. doi: 10.3389/fmicb.2018.02655.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02655</ArticleId><ArticleId IdType="pmc">PMC6284052</ArticleId><ArticleId IdType="pubmed">30555425</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal JE. HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease. J Int Assoc Provid AIDS Care. 2019;18:2325958219867315. doi: 10.1177/2325958219867315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325958219867315</ArticleId><ArticleId IdType="pmc">PMC6900575</ArticleId><ArticleId IdType="pubmed">31429353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep. 2016;6:22551. doi: 10.1038/srep22551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22551</ArticleId><ArticleId IdType="pmc">PMC4776094</ArticleId><ArticleId IdType="pubmed">26936108</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Prandovszky E, Kannan G, Pletnikov MV, Dickerson F, Severance EG, Yolken RH. Toxoplasma gondii: biological parameters of the connection to schizophrenia. Schizophr Bull. 2018;44(5):983&#x2013;992. doi: 10.1093/schbul/sby082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sby082</ArticleId><ArticleId IdType="pmc">PMC6101499</ArticleId><ArticleId IdType="pubmed">29889280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. Long COVID-19&#x2013;-it's not over until? Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7832095</ArticleId><ArticleId IdType="pubmed">33316400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533&#x2013;535. doi: 10.1038/s41423-020-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541&#x2013;543. doi: 10.1038/s41423-020-0401-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0401-3</ArticleId><ArticleId IdType="pmc">PMC7091621</ArticleId><ArticleId IdType="pubmed">32203186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>